The agency’s decision is supported by an overwhelming evidence base. Why did it take so long?
The Food and Drug Administration is facing backlash from anti-vaping members of Congress and other public-health campaigners for officially authorizing an e-cigarette as “appropriate for the protection of public health.”
The FDA’s decision to approve the Vuse Solo e-cigarette last month is a historic one: It marks the first time that America’s leading public-health agency officially recognized the potential of e-cigarettes to help smokers quit.
“The manufacturer’s data demonstrates its tobacco-flavored products could benefit addicted adult smokers who switch to these products — either completely or with a significant reduction in cigarette consumption,” said Mitch Zeller, head of the FDA’s Center for Tobacco Products.
The FDA’s decision is both welcome and overdue. Indeed, it’s been clear for many years that e-cigarettes are dramatically safer than combustible cigarettes; the evidence base that supports it is overwhelming to boot. The U.S. has nevertheless consistently lagged behind other countries — such as the U.K., France, and New Zealand — in recognizing the science of tobacco harm reduction.
Guy Bentley – National Review – 2021-11-02.
Want More Investigative Content?
